High-Dose Post-Transplant Cyclophosphamide, Bortezomib, and Sitagliptin for the Prevention of GVHD

Clinical trial NCT05895201 · WITHDRAWN

Trial details

NCT number: NCT05895201
Sponsor: Indiana University
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Bone Marrow Transplant Complications Acute Myeloid Leukemia Acute Lymphoblastic Leukemia, Adult Myelodysplastic Syndromes Chronic Myelomonocytic Leukemia

Start date: 2023-11-01
Primary completion: 2025-12-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.